Lovastatin-induced apoptosis is modulated by geranylgeraniol in a neuroblastoma cell line

International Journal of Developmental Neuroscience

Volumn 30, Issue 6, 2012, Pages 451-456

  Marcuzzi, Annalisa ^a   Zanin, Valentina ^a   Piscianz, Elisa ^a   Tricarico, Paola Maura ^b   Vuch, Josef ^a   Girardelli, Martina ^a   Monasta, Lorenzo ^a   Bianco, Anna Monica ^a   Crovella, Sergio ^a,b  

^a INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Geranylgeraniol; Isoprenoids; Lovastatin; Mevalonate kinase deficiency; Neuronal apoptosis

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; GERANYLGERANIOL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; MEVALONATE KINASE; MEVALONIC ACID; MEVINOLIN;

APOPTOSIS; ARTICLE; BIOLOGICAL MODEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ANALYSIS; ENZYME REGULATION; HUMAN; HUMAN CELL; MEVALONIC ACIDURIA; MOLECULAR PATHOLOGY; NEUROBLASTOMA CELL; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; APOPTOSIS; CASPASES; CELL LINE, TUMOR; DITERPENES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOVASTATIN; NEUROBLASTOMA; TIME FACTORS;

EID: 84865860489     PISSN: 07365748     EISSN: 1873474X     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2012.06.002     Document Type: Article

References (26)

1. Arnold D.E., Gagne C., Niknejad N., McBurney M.W., Dimitroulakos J. Lovastatin induces neuronal differentiation and apoptosis of embryonal carcinoma and neuroblastoma cells: enhanced differentiation and apoptosis in combination with dbcAMP?. Molecular and Cellular Biochemistry 2010, 345(1-2):1-11.
2. Bodar E.J., van der Hilst J.C., Drenth J.P., van der Meer J.W., Simon A. Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model. Netherlands Journal of Medicine 2005, 63(7):260-264.
3. Campia I., Luissiana C., Pescarmona G., Ghigo D., Bosia A., Riganti C. Geranylgeraniol prevents the cytotoxic effects of mevastatin in THP-1 cells, without decreasing the beneficial effects on cholesterol synthesis. British Journal of Pharmacology 2009, 158(7):1777-1786.
4. Celec P., Behuliak M. The lack of non-steroid isoprenoids causes oxidative stress in patients with mevalonic aciduria. Medical Hypotheses 2008, 70(5):938-940.
5. Chapman-Shimshoni D., Yuklea M., Radnay J., Shapiro H., Lishner M. Simvastatin induces apoptosis of B-CLL cells by activation of mitochondrial caspase 9. Experimental Hematology 2003, 31(9):779-783.
6. Corsini A., Maggi F.M., Catapano A.L. Pharmacology of competitive inhibitors of HMG-CoA reductase. Pharmacological Research 1995, 31(1):9-27.
7. D'Amelio M., Cavallucci V., Cecconi F. Neuronal caspase-3 signaling: not only cell death. Cell Death and Differentiation 2010, 17(7):1104-1114.
8. De Leo L., Marcuzzi A., Decorti G., Tommasini A., Crovella S., Pontillo A. Targeting farnesyl-transferase as a novel therapeutic strategy for mevalonate kinase deficiency: in vitro and in vivo approaches. Pharmacological Research 2010, 61(6):506-510.
9. Dietschy J.M., Turley S.D. Thematic review series: brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. Journal of Lipid Research 2004, 45(8):1375-1397.
10. Goldstein J.L., Brown M.S. Regulation of the mevalonate pathway. Nature 1990, 343(6257):425-430.
11. Green D.R., Kroemer G. The pathophysiology of mitochondrial cell death. Science 2004, 305(5684):626-629.
12. Haas D., Hoffmann G.F. Mevalonate kinase deficiencies: from mevalonic aciduria to hyperimmunoglobulinemia D syndrome. Orphanet Journal of Rare Diseases 2006, 1:13.
13. Haas D., Hoffmann G.F. Mevalonate kinase deficiency and autoinflammatory disorders. New England Journal of Medicine 2007, 356(26):2671-2673.
14. Herrero-Martin G., Lòpez-Rivas A. Statins activate a mitochondria-operated pathway of apoptosis in breast tumor cells by a mechanism regulated by ErbB2 and dependent on the prenylation of proteins. FEBS Letters 2008, 582(17):2589-2594.
15. Hooff G.P., Peters I., Wood W.G., Muller W.E., Eckert G.P. Modulation of cholesterol, farnesylpyrophosphate, and geranylgeranylpyrophosphate in neuroblastoma SH-SY5Y-APP695 cells: impact on amyloid beta-protein production. Molecular Neurobiology 2010, 41(2-3):341-350.
16. Huang Z., Hou Q., Cheung N.S., Li Q.T. Neuronal cell death caused by inhibition of intracellular cholesterol trafficking is caspase dependent and associated with activation of the mitochondrial apoptosis pathway. Journal of Neurochemistry 2006, 97(1):280-291.
17. Mailman T., Hariharan M., Karten B. Inhibition of neuronal cholesterol biosynthesis with lovastatin leads to impaired synaptic vesicle release even in the presence of lipoproteins or geranylgeraniol. Journal of Neurochemistry 2011, 119(5):1002-1015.
18. Mandey S.H., Kuijk L.M., Frenkel J., Waterham H.R. A role for geranylgeranylation in interleukin-1beta secretion. Arthritis and Rheumatism 2006, 54(11):3690-3695.
19. Marcuzzi A., Piscianz E., Girardelli M., Crovella S., Pontillo A. Defect in mevalonate pathway induces pyroptosis in raw 264.7 murine monocytes. Apoptosis 2011, 16(9):882-888.
20. Marcuzzi A., Tommasini A., Crovella S., Pontillo A. Natural isoprenoids inhibit LPS induced-production of cytokines and nitric oxide in aminobisphosphonate-treated monocytes. International Immunopharmacology 2010, 10(6):639-642.
21. Moosmann B., Behl C. Selenoprotein synthesis and side-effects of statins. Lancet 2004, 363(9412):892-894.
22. Pfrieger F.W. Outsourcing in the brain: do neurons depend on cholesterol delivery by astrocytes?. Bioessays 2003, 25(1):72-78.
23. Roensch J., Crisby M., Nordberg A., Xiao Y., Zhang L.J., Guan Z.Z. Effects of statins on alpha7 nicotinic receptor, cholinesterase and alpha-form of secreted amyloid precursor peptide in SH-SY5Y cells. Neurochemistry International 2007, 50(6):800-806.
24. Schulze-Osthoff K., Ferrari D., Los M., Wesselborg S., Peter M.E. Apoptosis signaling by death receptors. European Journal of Biochemistry 1998, 254(3):439-459.
25. Sierra S., Ramos M.C., Molina P., Esteo C., Vazquez J.A., Burgos J.S. Statins as neuroprotectants: a comparative in vitro study of lipophilicity, blood-brain-barrier penetration, lowering of brain cholesterol, and decrease of neuron cell death. Journal of Alzheimer's Disease 2011, 23(2):307-318.
26. Wong W.W., Dimitroulakos J., Minden M.D., Penn L.Z. HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis. Leukemia 2002, 16(4):508-519.